Key facts
- This page summarizes Joanne M. Foody's Form 4 filing for Esperion Therapeutics, Inc. (ESPR).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Jul 2024, 08:29.
Joanne M. Foody - 17 Jul 2024 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)
- Reporting relationship
- Chief Medical Officer
- Issuer ticker
- ESPR
- Reported as of
- 17 Jul 2024
- Net transaction value
- -$2,383
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2024, 08:29:55 UTC
- Prior SEC filing
- 20 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sheldon L. Koenig, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joanne M. Foody filed Form 4 for Esperion Therapeutics, Inc. (ESPR) on 19 Jul 2024.
Change
- Previous filing in this sequence was filed on 20 Jun 2024.
- Current net transaction value: -$2,383.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ESPR
transaction
Common Stock
Sale
- Transaction value
- $2,383
- Shares
- -917
- Change %
- -0.33%
- Price
- $2.60
- Shares after
- 272,862
- Date
- 17 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares were sold to satisfy tax obligation on vested shares of restricted stock units.